WSCM
ICCM icon

Wellington Shields Capital Management’s IceCure Medical ICCM Stock Holding History

Wellington Shields Capital Management’s Portfolio ICCM Stock Details ICCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4.51K Hold
500
– – ﹤0.01% 322
2025
Q4 		$9.15K Buy
+500
New +$11.2K ﹤0.01% 313

Other funds holding ICCM

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
CIA
Concurrent Investment Advisors Tampa, Florida $11.8B AUM 31.86% 1-Year Est. Return
WAM
Warberg Asset Management Winnetka, Illinois $600M AUM 23.37% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return
GCM
Gunderson Capital Management Mt. Pleasant, South Carolina $370M AUM 211.56% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
KFG
Kingdom Financial Group Peoria, Arizona $349M AUM 12.25% 1-Year Est. Return

Wellington Shields Capital Management's ICCM Position: Q1 2026 in Review

Wellington Shields Capital Management held its IceCure Medical (ICCM) position steady in Q1 2026 at 500 shares worth $4.51K. The position accounts for ﹤0.01% of the portfolio, ranked #322.

Wellington Shields Capital Management first reported a position in ICCM in Q4 2025 and has held it in 2 quarters since. The position peaked at $9.15K in Q4 2025. 17 funds tracked by Wall St. Rank hold ICCM as of Q1 2026.

  • Wellington Shields Capital Management held 500 shares of IceCure Medical worth $4.51K as of Q1 2026.
  • Wellington Shields Capital Management left its IceCure Medical share count unchanged in Q1 2026.
  • IceCure Medical made up ﹤0.01% of Wellington Shields Capital Management's portfolio in Q1 2026, its #322 holding.
  • Wellington Shields Capital Management first reported a position in IceCure Medical in Q4 2025 and has held it in 2 quarters since.
  • Wellington Shields Capital Management's IceCure Medical position peaked at $9.15K in Q4 2025.
  • 17 funds tracked by Wall St. Rank held IceCure Medical as of Q1 2026.

Based on Wellington Shields Capital Management's 13F filing for Q1 2026, filed 4 May 2026.